Kanen Wealth Management LLC increased its position in Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) by 108.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,969,541 shares of the company's stock after purchasing an additional 1,544,529 shares during the quarter. Quipt Home Medical makes up about 2.8% of Kanen Wealth Management LLC's investment portfolio, making the stock its 12th largest holding. Kanen Wealth Management LLC owned about 6.83% of Quipt Home Medical worth $6,919,000 at the end of the most recent reporting period.
Quipt Home Medical Stock Down 2.4%
QIPT stock traded down $0.05 on Friday, reaching $2.00. 227,344 shares of the company traded hands, compared to its average volume of 376,845. Quipt Home Medical Corp. has a one year low of $1.35 and a one year high of $4.07. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.22 and a quick ratio of 0.87. The company has a market cap of $87.01 million, a P/E ratio of -11.76 and a beta of 0.56. The firm has a fifty day simple moving average of $1.97 and a 200-day simple moving average of $2.44.
Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.09). Quipt Home Medical had a negative net margin of 2.90% and a negative return on equity of 6.70%. The company had revenue of $57.40 million for the quarter, compared to the consensus estimate of $88.29 million. Research analysts anticipate that Quipt Home Medical Corp. will post -0.05 earnings per share for the current year.
Analysts Set New Price Targets
A number of research firms have recently commented on QIPT. Wall Street Zen cut Quipt Home Medical from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Canaccord Genuity Group restated a "hold" rating and issued a $1.70 target price (down previously from $4.00) on shares of Quipt Home Medical in a research note on Tuesday, May 13th. Finally, Benchmark restated a "buy" rating and issued a $4.00 target price (down previously from $6.00) on shares of Quipt Home Medical in a research note on Wednesday, May 14th.
Get Our Latest Report on Quipt Home Medical
Quipt Home Medical Company Profile
(
Free Report)
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Featured Stories
Before you consider Quipt Home Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.
While Quipt Home Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
